![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Torrent Pharmaceuticals Limited Ahmedabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their significant offerings is Repaglinide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-308 - Rev 00
This Chemical Type CEP, issued on August 18, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2135 associated with this CEP further emphasizes